medigraphic.com
ISSN 0185-6014 (Print)
Órgano oficial de difusión de la Federación Mexicana de Patología Clínica, AC y de la Asociación Latinoamericana de Patología Clínica/Medicina de Laboratorio

2016, Number 4

<< Back Next >>

Rev Mex Patol Clin Med Lab 2016; 63 (4)

Intestinal perforation caused by type II enteropathy-associated T-cell lymphoma

Lazos OM, Pasillas BC, Romero FR, Romero CR

Language: English
References: 22
Page: 202-205
PDF size: 360.53 Kb.


ABSTRACT

Primary lymphomas of the small intestine are rare. Clinical features at presentation and prognosis are variable. T-cell lymphomas may or may not be associated with enteropathy but if it has been previously diagnosed it can present a range of clinical features, show peculiar evolution and affect prognosis. This report describes the case of a patient with insidious gastrointestinal symptoms, who received no treatment, and with no known gastrointestinal alterations. The sudden and unexpected presentation, despite being common with enteropathy-associated T-cell lymphoma (EATL), meant that the diagnosis was unforeseen. It is important to keep in mind the possibility of this diagnosis in the case of a patient with abdominal symptoms and no previous clinical history of this kind of disorder.


REFERENCES

  1. Lazos-Ochoa M, Valdés-Lías R. Linfomas intestinales. Rev Med Hosp Gen Mex. 1988; 61 (1): 41-46.

  2. Bush RS. Primary lymphomas of the gastrointestinal tract. JAMA. 1974; 228 (10): 1291-1294.

  3. Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer. 1972; 29 (1): 252-260.

  4. Grogan TM, Fielder K, Rangel C et al. Peripheral T-cell lymphoma: aggressive disease with heterogeneous inmunotypes. Am J Clin Pathol. 1985; 83: 279-287.

  5. Salter DM, Krajewski AS, Dewar AE. Immunophenotype analysis of malignant histiocytosis of the intestine. J Clin Pathol. 1986; 39 (1): 8-15.

  6. Zettl A, deLeeuw R, Haralambieva E, Mueller-Hermelink HK. Enteropathy-type T-cell lymphoma. Am J Clin Pathol. 2007; 127 (5): 701-706.

  7. Isaacson P, Wright DH. Malignant histiocytosis of the intestine. Its relationship to malabsorption and ulcerative jejunitis. Hum Pathol. 1978; 9 (6): 661-677.

  8. O’Farrelly C, Feighery C, O’Briain DS, Stevens F, Connolly CE, McCarthy C et al. Humoral response to wheat protein in patients with coeliac disease and enteropathy associated T cell lymphoma. Br Med J (Clin Res Ed). 1986; 293 (6552): 908-910.

  9. Busto-Bea V, Crespo-Pérez L, Rodríguez-Gandía MA, Roy-Ariño G, García-Miralles N, Cano-Ruiz A. Enteropathy-associated T-cell lymphoma: a diagnostic challenge. Gastroenterol Hepatol. 2011; 34 (10): 686-689.

  10. Cooper BT, Holmes GK, Cooke WT. Lymphoma risk in coeliac disease of later life. Digestion. 1982; 23 (2): 89-92.

  11. Ho-Yen C, Chang F, van der Walt J, Mitchell T, Ciclitira P. Recent advances in refractory coeliac disease: a review. Histopathology. 2009; 54 (7): 783-795.

  12. Attygalle AD, Cabeçadas J, Gaulard P, Jaffe ES, de Jong D, Ko YH et al. Peripheral T-cell and NK-cell lymphomas and their mimics; taking a step forward - report on the lymphoma workshop of the XVIth meeting of the European Association for Haematopathology and the Society for Hematopathology. Histopathology. 2014; 64 (2): 171-199.

  13. Molina-Villaverde R, Jiménez-Gordo A, López-González JL, Redondo-Sánchez A, Andreu-Rodríguez M, González-Barón M. Linfoma T primario intestinal: a propósito de dos casos con revisión de la literatura. An Med Interna (Madrid). 2002; 19 (9): 457-459.

  14. Chan JK, Chan AC, Cheuk W, Wan SK, Lee WK, Lui YH et al. Type II enteropathy-associated T-cell lymphoma: a distinct aggressive lymphoma with frequent γδ T-cell receptor expression. Am J Surg Pathol. 2011; 35 (10): 1557-1569.

  15. Green PH, Cellier C. Celiac disease. N Engl J Med. 2007; 357 (17): 1731-1743.

  16. Ryan BM, Kelleher D. Refractory celiac disease. Gastroenterology. 2000; 119 (1): 243-251.

  17. Rubio-Tapia A, Kyle RA, Kaplan EL, Johnson DR, Page W, Erdtmann F et al. Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology. 2009; 137 (1): 88-93.

  18. Felipe-Silva A, de Campos FF, de Medeiros RSS, Lourenção RM, Zerbini MCN. Enteropathy-associated T-cell lymphoma (type II): a Brazilian case report. Autopsy and Case Reports. 2012; 2 (2): 31-36.

  19. Pietzak MM. Follow-up of patients with celiac disease: achieving compliance with treatment. Gastroenterology. 2005; 128 (4 Suppl 1): S135-S141.

  20. Halfdanarson TR, Rubio-Tapia A, Ristow KM, Habermann TM, Murray JA, Inwards DJ. Patients with celiac disease and B-cell lymphoma have a better prognosis than those with T-cell lymphoma. Clin Gastroenterol Hepatol. 2010; 8 (12): 1042-1047.

  21. Leffler DA, Dennis M, Hyett B, Kelly E, Schuppan D, Kelly CP. Etio­logies and predictors of diagnosis in nonresponsive celiac disease. Clin Gastroenterol Hepatol. 2007; 5 (4): 445-450.

  22. Verbeek WH, von Blomberg BM, Coupe VM, Daum S, Mulder CJ, Schreurs MW. Aberrant T-lymphocytes in refractory coeliac disease are not strictly confined to a small intestinal intraepithelial localization. Cytometry B Clin Cytom. 2009; 76 (6): 367-374.




2020     |     www.medigraphic.com